𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Environmental Risk Assessment of Human Pharmaceuticals in the European Union - A Case Study with the β-blocker Atenolol

✍ Scribed by Küster, Anette; Alder, Alfredo C.; Escher, Beate; Duis, Karen; Fenner, Kathrin; Garric, Jeanne; Hutchinson, Tom; Lapen, David; Péry, Alexandre; Römbke, Jörg; Snape, Jason; Ternes, Thomas; Topp, Ed; Wehrhan, Anne; Knacker, Thomas

Book ID
120232921
Publisher
Society of Environmental Toxicology and Chemistry
Year
2007
Tongue
English
Weight
161 KB
Volume
preprint
Category
Article
ISSN
1551-3777

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Environmental risk assessment for the se
Environmental risk assessment for the serotonin re-uptake inhibitor fluoxetine: Case study using the European risk assessment framework
✍ Ken D Oakes; Anja Coors; Beate I Escher; Kathrin Fenner; Jeanne Garric; Marion G 📂 Article 📅 2010 🏛 Society of Environmental Toxicology and Chemistry 🌐 English ⚖ 267 KB

## Abstract The serotonin re‐uptake inhibitor fluoxetine was selected for an environmental risk assessment, using the most recent European guideline (EMEA 2006) within the European Union (EU)‐funded Environmental Risk Assessment of Pharmaceuticals (ERAPharm) project due to its environmental persist